nih glp 1 The Clinical Application of GLP-1RAs and GLP-1/GIP Dual Receptor Agonists Based on Pharmacological Mechanisms: A Review Glucagon-like peptide 1 (GLP-1) -
Description
18:e70079
GLP-1R is expressed in the pancreatic islets, heart, brain, kidney, gastrointestinal tract and lungs (15,17,18)
As such, a stable GIP agonist has been demonstrated to improve bone quality in rats [867], whereas DPP-4 inhibition positively modified bone composition but not bone microstructure in high fat fed mice [868]
[DOI] [PubMed] [Google Scholar] 194.Pinto S, et al
The higher the gauge, the thinner the needle
Hill C, Guarner F, Reid G, et al
